Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126102281 | 12610228 | 1 | I | 20160612 | 20160721 | 20160801 | 20160801 | EXP | GB-MHRA-EYC 00142574 | GB-MYLANLABS-2016M1030378 | MYLAN | 0.00 | Y | 0.00000 | 20160801 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126102281 | 12610228 | 1 | PS | ISOTRETINOIN | ISOTRETINOIN | 1 | Oral | 60 MG, UNK | U | U | 75945 | 60 | MG | ||||||
| 126102281 | 12610228 | 2 | C | LYMECYCLINE | LYMECYCLINE | 1 | UNK | U | 0 | ||||||||||
| 126102281 | 12610228 | 3 | C | RIGEVIDON /00022701/ | ETHINYL ESTRADIOLLEVONORGESTREL | 1 | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126102281 | 12610228 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126102281 | 12610228 | Alopecia | |
| 126102281 | 12610228 | Chapped lips | |
| 126102281 | 12610228 | Dry eye | |
| 126102281 | 12610228 | Haemorrhoids | |
| 126102281 | 12610228 | Oral herpes | |
| 126102281 | 12610228 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126102281 | 12610228 | 1 | 20160610 | 0 |